Latest Headlines
-
Sakura Finetek Europe Launches Sakura Pathology Network
9/17/2026
Sakura Finetek Europe today announced the launch of the Sakura Pathology Network (SPN), a new European network bringing together early-career pathologists from across Europe.
-
Siemens Healthineers Brings New CN-3000 And CN-6000 Hemostasis Testing Systems To US Labs To Help Manage Growing Workloads
9/16/2026
Siemens Healthineers announced today that the automated hemostasis analyzers for mid- and high-volume laboratories are now available for patient testing in the United States.
-
Co-Diagnostics And ReadyGo Collaborate To Evaluate Blood-Based Molecular Testing At The Point Of Need, Starting With Ebola
9/16/2026
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests and ReadyGo Diagnostics Ltd. ("ReadyGo"), a UK-based developer of field sample-preparation technology, today announced that the companies are collaborating to evaluate the potential use of ReadyGo's sample-preparation technology with the Co-Dx PCR platform for blood-based molecular testing at the point of need, with an initial focus on decentralized Ebola virus detection and outbreak response (the "Collaboration").
-
Aptitude Announces FDA 510(k) Clearance Of Next-Generation Metrix® COVID Test
9/16/2026
Aptitude today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the next-generation Metrix® COVID Test, marking the company's first FDA 510(k) clearance and the continued expansion of the Metrix molecular diagnostics platform.
-
Augurex Announces Mayo Clinic Laboratories Now Offering 14-3-3eta Testing For Rheumatoid Arthritis
9/15/2026
Augurex Life Sciences Corp., a commercial-stage diagnostics company focused on autoimmune and inflammatory diseases, today announced that Mayo Clinic Laboratories is now offering 14-3-3eta serum testing for rheumatoid arthritis (RA) in the United States.
-
Zifo And Alchemy Partner To Advance AI-Enabled R&D Across Formulation And Materials Industries
9/15/2026
Zifo, a leading global enabler of AI and data-driven enterprise informatics for science-driven organizations, today announced a strategic partnership with Alchemy Cloud to help formulation- and materials-driven companies build connected, AI-enabled R&D environments, unlock greater value from scientific data, and bring better, more sustainable products to market faster.
-
ADLM Calls For CLIA Updates To Help Ensure Safe And Reliable Use Of AI In Laboratory Medicine
9/15/2026
The Association for Diagnostics & Laboratory Medicine (ADLM) has submitted comments in response to a federal request for information regarding potential updates to the Clinical Laboratory Improvement Amendments (CLIA), which are a set of regulatory standards that govern all clinical laboratory testing in the U.S. In the comment letter, ADLM recommends that, under CLIA, emerging artificial intelligence (AI) tools should remain subject to the same professional expertise, quality systems, validation requirements, and monitoring standards that apply to traditional laboratory testing.
-
Waters Sets Benchmark For Standardized Spectral Flow Cytometry With Commercial Launch Of BD FACSDiscover A7 Cell Analyzer
9/14/2026
Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with industry-leading standardization and ease-of-use features, making the power of advanced flow cytometry more accessible to researchers in academia and pharmaceutical settings, as well as in contract research organization (CRO) labs.
-
BRAINBox Solutions Announces Agreement With Prolight Diagnostics For Commercial Supply Of Pyros® Devices For Delivery Of BRAINBox Concussion Diagnostics/Prognostics At Point-Of-Care
9/14/2026
BRAINBox Solutions today announced it has entered into an agreement with Prolight Diagnostics to supply its Pyros® instruments and cartridges for use in point-of-care (PoC) delivery of BRAINBox's TBI diagnostic/prognostic tests for concussion (also known as mTBI or Acute Traumatic Encephalopathy).
-
Aston University And Labskin Team Up To Improve Human Skin Models For Medical Research
9/14/2026
Labskin specialises in producing complex skin models that closely replicate the structure of real skin. These models – which come in thumbnail-sized sections around 1cm thick – are used by academic researchers and companies to study how products and treatments interact with the skin before they are trialled in people.